IRIS
RODOLICO, Carmelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.323
NA - Nord America 12.171
AS - Asia 6.881
SA - Sud America 2.397
Continente sconosciuto - Info sul continente non disponibili 566
AF - Africa 187
OC - Oceania 9
AN - Antartide 1
Totale 34.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.904
RU - Federazione Russa 6.327
SG - Singapore 2.872
BR - Brasile 2.024
CN - Cina 1.963
IE - Irlanda 1.500
SE - Svezia 1.163
HK - Hong Kong 795
IT - Italia 721
DE - Germania 578
UA - Ucraina 460
FR - Francia 394
VN - Vietnam 375
FI - Finlandia 321
PL - Polonia 314
GB - Regno Unito 241
IN - India 178
AR - Argentina 132
BD - Bangladesh 126
CA - Canada 124
TR - Turchia 95
NL - Olanda 71
BE - Belgio 60
MX - Messico 58
ZA - Sudafrica 58
ID - Indonesia 56
VE - Venezuela 55
EC - Ecuador 52
IQ - Iraq 51
CO - Colombia 47
JP - Giappone 45
AT - Austria 43
PK - Pakistan 42
UZ - Uzbekistan 40
ES - Italia 33
PY - Paraguay 30
MA - Marocco 29
MY - Malesia 23
TN - Tunisia 23
CI - Costa d'Avorio 19
CZ - Repubblica Ceca 19
PE - Perù 19
CL - Cile 18
JM - Giamaica 18
AZ - Azerbaigian 17
KE - Kenya 17
LT - Lituania 17
AE - Emirati Arabi Uniti 16
IL - Israele 16
JO - Giordania 16
IR - Iran 14
KZ - Kazakistan 14
NP - Nepal 14
SA - Arabia Saudita 14
PH - Filippine 13
EG - Egitto 12
GT - Guatemala 12
TH - Thailandia 12
UY - Uruguay 11
DO - Repubblica Dominicana 10
LB - Libano 10
OM - Oman 10
DZ - Algeria 9
BO - Bolivia 8
CR - Costa Rica 8
KG - Kirghizistan 8
AM - Armenia 7
AU - Australia 6
EU - Europa 6
HN - Honduras 6
KR - Corea 6
PA - Panama 6
PS - Palestinian Territory 6
CH - Svizzera 5
NI - Nicaragua 5
RO - Romania 5
RS - Serbia 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
GR - Grecia 4
KW - Kuwait 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
AO - Angola 3
BH - Bahrain 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
HU - Ungheria 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
BB - Barbados 2
BN - Brunei Darussalam 2
DK - Danimarca 2
GA - Gabon 2
Totale 33.930
Salva come PNG Salva come JPEG
Città #
Moscow 1.911
Ashburn 1.567
Dublin 1.491
Singapore 1.473
Dallas 1.192
Chandler 1.072
Jacksonville 941
Hong Kong 793
Nyköping 710
Beijing 685
San Jose 558
Council Bluffs 480
The Dalles 356
Warsaw 299
Princeton 274
Los Angeles 266
Lauterbourg 240
Medford 229
Cambridge 225
Ann Arbor 201
Des Moines 193
Dearborn 174
New York 156
Messina 146
São Paulo 144
Munich 129
Buffalo 127
Ho Chi Minh City 126
Boardman 109
Tianjin 100
Wilmington 85
Hanoi 78
Guangzhou 75
Santa Clara 75
Shenyang 73
Jinan 72
San Mateo 70
Nanjing 64
Orem 64
Belo Horizonte 63
Frankfurt am Main 63
Turku 60
Rio de Janeiro 59
Redondo Beach 57
Rome 55
Atlanta 54
Brooklyn 53
Bremen 50
Woodbridge 48
Lancaster 45
Brussels 41
Hyderabad 40
Ningbo 39
Istanbul 38
Tokyo 38
Columbus 37
Houston 37
Shanghai 36
Tashkent 35
Hebei 34
Catania 33
Montreal 33
Pune 33
Seattle 33
Brasília 31
Chennai 31
Helsinki 31
Milan 31
Hangzhou 30
San Francisco 30
Denver 29
Haikou 28
Zhengzhou 28
Dong Ket 26
Falls Church 26
Phoenix 26
Stockholm 26
Amsterdam 25
Campinas 25
Nuremberg 25
Porto Alegre 25
Shenzhen 25
Vienna 25
Boston 24
Curitiba 24
Johannesburg 24
Toronto 24
Guayaquil 23
Mumbai 22
Manchester 21
Dhaka 20
London 20
Naples 20
Ottawa 20
Taizhou 20
Abidjan 19
Baghdad 19
Jakarta 19
Salvador 19
Baku 17
Totale 19.015
Salva come PNG Salva come JPEG
Nome #
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 684
Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. 368
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 268
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 256
Clinical and pathological features of focal myositis 251
Le sindromi miasteniche congenite 239
Immune checkpoint inhibitors and neurotoxicity: a focus on diagnosis and management for a multidisciplinary approach 238
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 225
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 218
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 215
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 213
A life threatening case of β-enolase deficiency 205
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 201
Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy 200
Acute motor axonal polyneuropathy after a cisatracurium infusion and concomitant corticosteroid therapy. 198
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 198
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 195
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 195
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 193
Hippo signaling pathway is altered in Duchenne muscular dystrophy 192
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 192
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 182
Central and peripheral autonomic failure in cold induced sweating syndrome type 1 180
Advances in assessing myotonia: Can sensor-engineered glove have a role? 180
ANT1 is reduced in sporadic inclusion body myositis. 179
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 178
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 178
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 177
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 177
A standardized clinical evaluation of patients affected by facioscapulohumeralmuscular dystrophy: The FSHD clinical score. 176
Cardiovascular autonomic control in Becker muscular dystrophy 171
Apoptosis and apoptosis-related proteins in thyroid myopathies 170
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 170
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 170
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 169
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 168
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 168
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 168
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 167
Autoimmune juvenile limb-girdle myasthenia 166
Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis 166
Aging-associated genes and let-7 microRNAs: a contribution to myogenic program dysregulation in oculopharyngeal muscular dystrophy 162
Italian recommendations for the diagnosis and treatment of myasthenia gravis 161
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 161
Toward a more personalized motor function rehabilitation in myotonic dystrophy type 1: The role of neuroplasticity 161
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 158
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 158
A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes 158
A 5-year clinical follow-up study from the Italian National Registry for FSHD 158
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 158
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 157
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 156
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population 156
Miotonia congenita, epilessia, schizofrenia: un'insolita associazione 155
Involvement of miR-126 in autoimmune disorders 155
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 153
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 153
Fatal R631C mutation is also present in the adult form of CPTII deficiency 152
Severe rhabdomyolysis in a patient with “Heat Stroke” 152
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 150
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 150
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 150
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 150
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 150
A robust tool to quantify disability in patients affected by facio-scapulo-humeral muscular dystrophy. 149
MuSK-Associated Myasthenia Gravis: Clinical Features and Management 149
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease 148
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 148
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 147
Rituximab in AChR subtype of myasthenia gravis: systematic review 147
Endocrine myopathies: Clinical and histopathological features of the major forms 147
An unusual association of dominant optic atrophy with OPA1 mutations and parkinsonian syndrome. 146
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 146
Juvenile limb-girdle myasthenia gravis 145
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 144
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 143
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 143
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 143
Clinical, morphological and genetic features of a large cohort of late onset GSDII patients: typical and atypical presentation 143
Tetraplegia flaccida dopo prolungata infusione di cisatracurio 142
Calpain 3 deficiency in Quail Eater's disease 142
Cardiovascular autonomic control in myotonic dystrophy type 1: a correlative study with clinical and genetic data. 142
Amyloid myopathy presenting with rhabdomyolysis 141
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 140
Chanarin-Dorfman disease (CDD): clinical, genetic and neuroradiological aspects in an adult case followed over 25 years 138
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 138
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 137
Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy 137
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 136
LOCALIZATION OF VINCULIN AND TALIN AT PERINEURIAL CELLS OF HUMAN SURAL NERVE 136
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 136
Expression of the trascription factor NFkB in different muscular dystrophies 135
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 135
Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series 135
Amyloid myopathy presenting with rhabdomyolysis. 134
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 134
A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review 132
Autoimmune polyglandular disease (APECED) and mutineuropathy: a case report 131
Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects 130
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 130
Totale 17.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.643 0 215 20 71 82 23 169 76 35 174 207 571
2022/20234.254 343 361 182 298 343 428 42 262 1.818 19 120 38
2023/20241.025 97 174 70 86 78 208 34 46 2 82 31 117
2024/20255.383 88 41 77 312 219 148 138 1.113 1.330 345 560 1.012
2025/202615.786 809 1.124 1.251 1.077 1.246 3.340 1.930 1.874 1.846 710 307 272
2026/20271.726 846 880 0 0 0 0 0 0 0 0 0 0
Totale 34.535